The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Histaclar 10mg Film-coated Tablets

10 milligram(s) Coated tablet

McDermott Laboratories Ltd t/a Gerard LaboratoriesPA0577/046/001

Main Information

Trade NameHistaclar 10mg Film-coated Tablets
Active SubstancesLoratadine
Strength10 milligram(s)
Dosage FormCoated tablet
Licence HolderMcDermott Laboratories Ltd t/a Gerard Laboratories
Licence NumberPA0577/046/001

Group Information

ATC CodeR06AX Other antihistamines for systemic use
R06AX13 loratadine

Status

Authorised/WithdrawnAuthorised
Licence Issued24/01/2003
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back